首页> 外文期刊>Canadian journal of gastroenterology >Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.
【24h】

Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

机译:代偿性肝硬化患者单发1 cm至2 cm肝结节的处理:一项决策分析。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: Current guidelines, based on expert opinion, recommend that suspected 1 cm to 2 cm hepatocellular carcinoma (HCC) detected on screening be biopsied and, if positive, treated (eg, resection or transplantation). Alternative strategies are immediate treatment or observation until disease progression occurs. METHODS: A Markov decision model was developed that compared three management strategies - immediate resection, biopsy and resection if positive, and ultrasound surveillance every three months until disease progression - for a single 1 cm to 2 cm liver nodule suspicious for HCC following ultrasound screening and computed tomography confirmation. The cohort included 55-year-old patients with compensated cirrhosis and no significant comorbidities. The model used in the present study incorporated the probabilities of false-positive and false-negative results, needle-track seeding, HCC recurrence, cirrhosis progression and death. The quality-adjusted life expectancy (LE) and the unadjusted LE were evaluated and the model's strength was assessed with sensitivity analyses. RESULTS: In the base case analysis, biopsy, resection and surveillance yielded an unadjusted LE of 60.5, 59.7 and 56.6 months, respectively, and a quality-adjusted LE of 46.6, 45.6 and 43.8 months, respectively. In probabilistic sensitivity analyses, biopsy was the preferred strategy 69.5% of the time, resection 30.5% of the time and surveillance never. Resection was the optimal decision if the sensitivity of biopsy was very low (less than 0.45) or if the accuracy of the imaging tests resulted in a high percentage of HCC-positive patients (greater than 76%) in the screened cohort, as with expert interpretation of triphasic computed tomography. CONCLUSIONS: The present model suggests that biopsy is the preferred management strategy for these patients. When postimaging probability of HCC is high or pathology expertise is lacking, resection is the best alternative. Surveillance is never the optimal strategy.
机译:目的:根据专家意见,当前指南建议对筛查发现的疑似1 cm至2 cm肝细胞癌(HCC)进行活检,如果阳性,则应进行治疗(例如,切除或移植)。替代策略是立即治疗或观察直到疾病进展。方法:建立了一个马尔可夫决策模型,比较了三种管理策略:即刻切除,活检和切除(如果阳性),每三个月进行一次超声检查直至疾病进展-在超声检查和筛查后,对可疑HCC的单个1 cm至2 cm肝结节进行了比较。计算机断层扫描确认。该队列包括55岁的有代偿性肝硬化且无明显合并症的患者。本研究中使用的模型纳入了假阳性和假阴性结果,针迹播种,HCC复发,肝硬化进展和死亡的可能性。评估了质量调整后的预期寿命(LE)和未调整后的LE,并通过敏感性分析评估了模型的强度。结果:在基本病例分析中,活检,切除和监测的未调整LE分别为60.5、59.7和56.6个月,而质量调整LE分别为46.6、45.6和43.8个月。在概率敏感性分析中,活检是69.5%的时间,30.5%的时间切除率和从未进行过监视的首选策略。如果活检的敏感性非常低(小于0.45)或影像学检查的准确性导致筛查队列中HCC阳性患者的百分比较高(大于76%),则切除是最佳选择,如专家所述三角计算机断层扫描的解释。结论:本模型提示活检是这些患者的首选治疗策略。当肝癌的成像后可能性很高或缺乏病理学专业知识时,切除是最佳选择。监视永远都不是最佳策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号